Trichophyton mentagrophytes and trichophyton rubrum: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{DrugProjectFormSinglePage | {{DrugProjectFormSinglePage | ||
|authorTag={{KS}} | |||
|genericName=trichophyton mentagrophytes and trichophyton rubrum | |||
|aOrAn=a | |aOrAn=a | ||
|indicationType=treatment | |indicationType=treatment | ||
|hasBlackBoxWarning=Yes | |hasBlackBoxWarning=Yes | ||
|adverseReactions= | |adverseReactions= | ||
* This product is intended for use by physicians who are experienced in the administration of allergenic extracts or for use under the guidance of an allergy specialist. Skin tests should be performed after the patient's physical well being and allergic history have been evaluated. Patients should be instructed to recognize adverse reaction symptoms and cautioned to contact the physician if symptoms occur. As with all allergenic extracts, severe systemic reactions may occur, and in certain individuals these reactions may cause death. Patients should be observed for at least 20 minutes after skin tests have been completed. Emergency measures as well as personnel trained in their use should be immediately available in the event of a life threatening reaction. | |||
* This product should never be injected intravenously. | |||
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i> | ||
Line 244: | Line 249: | ||
<!--Drug Interactions--> | <!--Drug Interactions--> | ||
|useInPregnancyFDA=* '''Pregnancy Category''' | |useInPregnancyFDA=* '''Pregnancy Category''' | ||
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' | |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category''' |
Revision as of 19:12, 27 March 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
|
Overview
Trichophyton mentagrophytes and trichophyton rubrum is a {{{drugClass}}} that is FDA approved for the treatment of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include * This product is intended for use by physicians who are experienced in the administration of allergenic extracts or for use under the guidance of an allergy specialist. Skin tests should be performed after the patient's physical well being and allergic history have been evaluated. Patients should be instructed to recognize adverse reaction symptoms and cautioned to contact the physician if symptoms occur. As with all allergenic extracts, severe systemic reactions may occur, and in certain individuals these reactions may cause death. Patients should be observed for at least 20 minutes after skin tests have been completed. Emergency measures as well as personnel trained in their use should be immediately available in the event of a life threatening reaction.
- This product should never be injected intravenously..
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Condition1
- Dosing Information
- Dosage
Condition2
- Dosing Information
- Dosage
Condition3
- Dosing Information
- Dosage
Condition4
- Dosing Information
- Dosage
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Trichophyton mentagrophytes and trichophyton rubrum in adult patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Trichophyton mentagrophytes and trichophyton rubrum in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Trichophyton mentagrophytes and trichophyton rubrum in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Trichophyton mentagrophytes and trichophyton rubrum in pediatric patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Trichophyton mentagrophytes and trichophyton rubrum in pediatric patients.
Contraindications
- Condition1
Warnings
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
|
- Description
Precautions
- Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Drug Interactions
There is limited information regarding Trichophyton mentagrophytes and trichophyton rubrum Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Trichophyton mentagrophytes and trichophyton rubrum in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Trichophyton mentagrophytes and trichophyton rubrum during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum with respect to specific gender populations.
Race
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Trichophyton mentagrophytes and trichophyton rubrum in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Trichophyton mentagrophytes and trichophyton rubrum in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Pharmacology
There is limited information regarding Trichophyton mentagrophytes and trichophyton rubrum Pharmacology in the drug label.
Mechanism of Action
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
How Supplied
Storage
There is limited information regarding Trichophyton mentagrophytes and trichophyton rubrum Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Trichophyton mentagrophytes and trichophyton rubrum |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Trichophyton mentagrophytes and trichophyton rubrum |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Trichophyton mentagrophytes and trichophyton rubrum in the drug label.
Precautions with Alcohol
- Alcohol-Trichophyton mentagrophytes and trichophyton rubrum interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Page Name=Trichophyton mentagrophytes and trichophyton rubrum |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Trichophyton mentagrophytes and trichophyton rubrum |Label Name=Trichophyton mentagrophytes and trichophyton rubrum11.png
}}
{{#subobject:
|Label Page=Trichophyton mentagrophytes and trichophyton rubrum |Label Name=Trichophyton mentagrophytes and trichophyton rubrum11.png
}}